The RSI Indicator for PBYI moved out of oversold territory on August 16, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In of the 33 cases the stock moved higher. This puts the odds of a move higher at .
operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer
Industry Biotechnology